Question 1

What is Star Therapeutics?

Accepted Answer

Star Therapeutics is a Entity.

Question 2

How often does Star Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Star Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 08, 2026.

Question 4

When was Star Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 13, 2026.

Question 5

What is Star Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 55 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Star Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Star Therapeutics?

Accepted Answer

Incyte acquires Vega Therapeutics for VGA039 (Jun 08, 2026, 6 articles).

Question 8

How did the "Incyte acquires Vega Therapeutics for VGA039" event impact Star Therapeutics?

Accepted Answer

Star Therapeutics is selling its wholly owned subsidiary, Vega Therapeutics, to Incyte for a potential total consideration of up to $2 billion, reflecting a successful development of VGA039.

Question 9

How did the "Incyte latarcibart Phase 1/2 data" event impact Star Therapeutics?

Accepted Answer

Star Therapeutics is the parent company of Vega Therapeutics; the acquisition by Incyte monetized its subsidiary's asset.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.